{
  "actions": [
    {
      "acted_at": "2017-06-29", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2017-06-29", 
      "action_code": "", 
      "committees": [
        "SSHR"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s1509-115", 
  "bill_type": "s", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "115", 
  "cosponsors": [
    {
      "bioguide_id": "M000639", 
      "district": null, 
      "name": "Menendez, Robert", 
      "original_cosponsor": true, 
      "sponsored_at": "2017-06-29", 
      "state": "NJ", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "N000032", 
      "district": null, 
      "name": "Nelson, Bill", 
      "original_cosponsor": false, 
      "sponsored_at": "2017-08-02", 
      "state": "FL", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "S001184", 
      "district": null, 
      "name": "Scott, Tim", 
      "original_cosponsor": false, 
      "sponsored_at": "2017-08-02", 
      "state": "SC", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2017-06-29", 
  "number": "1509", 
  "official_title": "A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize an extension of exclusivity periods for certain drugs that are approved for a new indication for a rare disease or condition, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr1223-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017", 
  "sponsor": {
    "bioguide_id": "H000338", 
    "district": null, 
    "name": "Hatch, Orrin G.", 
    "state": "UT", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2017-06-29", 
  "subjects": [
    "Health"
  ], 
  "subjects_top_term": "Health", 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize an extension of exclusivity periods for certain drugs that are approved for a new indication for a rare disease or condition, and for other purposes.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017", 
      "type": "display"
    }
  ], 
  "updated_at": "2017-09-11T03:06:40Z", 
  "url": "https://www.gpo.gov/fdsys/bulkdata/BILLSTATUS/115/s/BILLSTATUS-115s1509.xml"
}